About Us
CSL Plasma, headquartered in Boca Raton, Florida, upholds a tradition
of innovation and excellence. As a leader in plasma collection, we are
committed to excellence and innovation in everything we do. Our work
ensures that tens of thousands of people are able to live normal, healthy
lives. We are committed to our work because people’s lives depend on us.
CSL Plasma is a division of CSL Behring, a plasma protein biotherapies
company headquartered in King of Prussia, Pennsylvania.
CSL Behring is a leader in the plasma protein therapeutics industry.
Committed to saving lives and improving the quality of life for people with
rare and serious diseases, the company manufactures and markets a range
of plasma-derived and recombinant therapies worldwide.
CSL Behring therapies are used around the world to treat coagulation
disorders including hemophilia and von Willebrand disease, primary immune
deficiencies, hereditary angioedema and inherited respiratory disease, and
neurological disorders in certain markets. The company’s products are
also used in cardiac surgery, organ transplantation, burn treatment and to
prevent hemolytic diseases in the newborn.
CSL Behring is a global biopharmaceutical company and a member of the
CSL Group of companies. The parent company, CSL Limited (ASX:CSL), is
headquartered in Melbourne, Australia. For more information, visit
http://www.cslbehring.com/.
CSLPlasma.com
Our History
How is Plasma Collected?
CSL Behring traces its corporate roots to the founding of
Behringwerke, a company established in 1904 by Emil von
Behring. For his work in serum therapy in 1901, Dr. von Behring
was the first recipient of the Nobel Prize for Medicine and
Physiology. CSL Behring is proud of a heritage that has delivered
“Biotherapies for Life” for more than a century.
We collect plasma using a process called “plasmapheresis”.
Plasmapheresis is a special process that separates the plasma
from the blood and collects it in a bottle. The uncollected parts
of the blood, including red blood cells and white blood cells, are
returned to the donor. This allows donors to donate up to two
times a week. The maximum frequency of donation is once in
two days, and no more than two times in a seven day period.
The collection procedure itself takes approximately 90 minutes.
We use a sophisticated high-tech machine that safely and
quickly collects the plasma and returns the other parts of the
blood to you. A needle is placed in the vein of the donor’s arm
and blood is collected using sterile equipment. The equipment is
disposable and is used only once.
CSL Behring is a subsidiary of CSL Limited (ASX:CSL), a
biopharmaceutical company headquartered in Melbourne,
Australia. CSL was initially formed in 1916 to supply vaccines
to the Australian government. CSL traces its core plasma
therapeutics business to the early 1950s when the company,
in collaboration with the Australian Red Cross, started
fractionating plasma on behalf of the Australian government.
Since listing as a public company in 1994, CSL has become a
world leader in plasma therapeutics.
What is Plasma?
Plasma is a straw-colored liquid that carries the red blood cells,
white blood cells and platelets. Plasma is made up of:
• Water (about 90%)
• Proteins and clotting factors (8%)
• Small amounts of salts, glucose (blood sugar) and lipids (fats)
It has a number of vital functions in bleeding and infection
control. It contains proteins and antibodies, which are produced
by the immune system to fight diseases.
Uses of Plasma
Plasma is the essential ingredient for products crucial to treating
patients suffering from a host of life–threatening conditions,
including hemophilia, shock or trauma, immune deficiencies
and other blood disorders. Our plasma collection centers, which
are located throughout the United States and Germany, are
committed to the highest standards of quality and safety.
When you donate, you give a valuable gift to those who require
plasma–derived therapies to live healthier lives.
CSLPlasma.com
Company Facts
Our Values
CSL Plasma
CSL Plasma, a division of CSL Behring, is owned
by CSL Limited based in Melbourne, Australia.
Innovation
We seek better ways of doing things
Headquarters
Boca Raton, Florida
Customer Focus
We are passionate about meeting the needs
of our customers
Website
cslplasma.com
Integrity
We are ethical and honest at all times
Employees
Over 4000
Collaboration
We work together to achieve better results
Collection Centers
Over 85 U.S. Sites
8 Germany Sites
Superior Performance
We strive to be the best at what we do
Testing Laboratories
Knoxville, TN
Göettingen, Germany
Logistics Centers
Indianapolis, IN
Mesquite, TX
Schwalmstadt, Germany
Corporate Contact
Scott Newkirk
561-912-3085
Patrick.Newkirk@CSLPlasma.com
Company Address
900 Broken Sound Parkway, Suite 400
Boca Raton, FL 33487
561.981.3700
CSLPlasma.com
Global Product Portfolio*
THERAPY
PRODUCT NAME
Coagulation
Helixate FS, Helixate NexGen
Recombinant coagulation factor VIII
Freeze-dried recombinant factor VIII
RiaSTAP®
Human coagulation factor I
Freeze-dried factor I concentrate
Monoclate P®
Human coagulation factor VIII
Freeze-dried monoclonal antibody purified
factor VIII concentrate
Beriate®
Human coagulation factor VIII
Freeze-dried factor VIII concentrate
Humate® P, Haemate® P
Human coagulation factor VIII /
von Willebrand factor complex
Freeze-dried factor VIII: C and von Willebrand
factor concentrate
Stimate®
Desmopressin
Synthetic desmopressin acetate nasal spray
Mononine®
Human coagulation factor IX
Freeze-dried monoclonal antibody purified
factor IX concentrate
Berinin® P
Human coagulation factor IX
Freeze-dried factor IX concentrate
Critical Care
®
N O N - P R O P R I E TA RY N A M E
®
Factor X P Behring
Human coagulation factor IX and X
Freeze-dried factor IX and factor X concentrate
Fibrogammin® P, Corifact®
Human coagulation factor XIII
Freeze-dried factor XIII concentrate
Octostim®
Desmopressin
Synthetic desmopressin acetate nasal spray
Beriplex® P/N, Kcentra™
Human prothrombin complex
Freeze-dried prothrombin complex concentrate
Haemocomplettan® P, RiaSTAP®
Human fibrinogen
Freeze-dried fibrinogen (factor I) concentrate
Kybernin® P
Human antithrombin III concentrate
Freeze-dried antithrombin III concentrate
AlbuRx®, Alburex, Human
Albumin Behring, Albuminar® 25
Human albumin solution
5%, 20% or 25% human albumin solutions
Berinert®
Human C1-esterase inhibitor
Freeze-dried C1-esterase inhibitor concentrate
Streptase
Streptokinase
Freeze-dried streptokinase
Hizentra®
Human normal immunoglobulin
Liquid 20% immunoglobulin solution, ready-touse for SC administration
Human polyvalent immunoglobulin
Liquid 10% solution for IV injection
Carimune NF, Sandoglobulin ,
Sanglopor®
Human normal immunoglobulin
Freeze-dried immunoglobulin formulations for
IV administration
Rhophylac®
Human anti-D immunoglobulin
Prefilled syringes of highly purified anti-Rhesus
factor D IgG for IV administration and IM
injection
Cytogam®
Human cytomegalovirus
immunoglobulin
Liquid immunoglobulin containing a standardized amount of antibody to cytomegalovirus
Human rabies immunoglobulin
Liquid 16% solution for IM injection
®
Immunology
PRODUCT DESCRIPTION
Privigen®
®
Berirab® P
®
Beriglobin P
Human hepatitis A immunoglobulin
Liquid 16% solution for IM injection
Hepatitis B Immunoglobulin
P Behring
Human hepatitis B immunoglobulin
Liquid 16% solution for IM injection
Tetagam® P
Human tetanus immunoglobulin
Liquid 16% solution for IM injection
Varicellon® P
Human varicella immunoglobulin
Liquid 16% solution for IM injection
®
Pulmonology
Zemaira
Human Alpha1-proteinase inhibitor
Freeze-dried Alpha1-proteinase inhibitor (A1-PI)
Wound
Healing
Beriplast® P Combi-Set
Fibrin sealant kit
Freeze-dried fibrin sealant for topical application
Fibrogammin® P
Human coagulation factor XIII
Freeze-dried factor XIII concentrate
TachoComb®
Fibrin sealant fleece-type
Fleece-type collagen preparations coated with
fibrin glue components
®
*Product availability varies from country to country, depending on registration status. Please contact your CSL Behring representative.
CSL Behring is a company of CSL Limited. July 2013
CSLPlasma.com
Product Pipeline
Our balanced research and development portfolio is divided into three categories: life cycle management, market development and
new product development.
Life Cycle Management
ensures continuous product improvement
by maintaining and increasing
competitiveness within our existing
product range
Market Development
brings therapies to new markets and
new indications by maximizing market
opportunities for our existing product
range.
Global R&D Pipeline September 2013
CSL362 IL-3R* Janssen
CSL112 reconstituted HDL
FXIIa Antagonist
CSLPlasma.com
New Product Development
creates specialty therapies to treat lifethreatening diseases. It ensures long-term
growth primarily through projects aligned
with our current marketing channels.